Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N02AA05	OXYNORM	B	Oxycodone HCl - 5mg	5mg	Capsule, hard	1,991,575 L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 10mg	10mg	Capsule, hard	3,988,525 L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 20mg	20mg	Capsule, hard	7,634,958 L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 10mg/ml	10mg/ml	Injectable solution	1,584,390 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.1%	0.1%	Solution	260,705 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.1%	0.1%	Drops	241,892 L.L
R01AA07	OTRIVIN MENTHOL 0.1%	B	Xylometazoline HCl - 0.1%	0.1%	Drops	387,027 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Solution	260,705 L.L
B05BA10	OLIMEL N9E	B	Glucose solution - 27.5%, Amino acids solution - 14.2%, Lipid emulsion - 20%, Sodium - 70mmol/2l, Potassium - 60mmol/2l, Magnesium - 8mmol/2l, Calcium - 7mmol/2l, Phosphate - 30mmol/2l, Acetate - 107mmol/2l, Chloride - 90mmol/2l, Azote - 18g/2l		Injectable emulsion	4,711,512 L.L
B05BA10	OLIMEL N9	B	Glucose solution - 27.5%, Amino acids solution - 14.2%, Lipid emulsion - 20%, Azote - 9g/l		Injectable emulsion	5,630,028 L.L
B05BA10	OLIMEL N9E	B	Glucose solution - 27.5%, Amino acids solution - 14.2%, Lipid emulsion - 20%, Sodium - 35mmol/l, Potassium - 30mmol/l, Magnesium - 4mmol/l, Calcium - 3.5mmol/l, Phosphate - 15mmol/l, Acetate - 54mmol/l, Chloride - 45mmol/l, Azote - 9g/l		Injectable emulsion	3,698,255 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Drops	181,419 L.L
B05BA10	OLIMEL N7E	B	Glucose solution - 35%, Amino acids solution - 11.1%, Lipid emulsion - 20%, Sodium - 35mmol/l, Potassium - 30mmol/l, Magnesium - 4mmol/l, Calcium - 3.5mmol/l, Phosphate - 15mmol/l, Acetate - 45mmol/l, Chloride - 45mmol/l, Azote - 7g/l		Injectable emulsion	3,698,255 L.L
C09DA08	OLMETEC PLUS	B	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 25mg		Tablet, film coated	981,005 L.L
B05BA10	OLIMEL N7E	B	Glucose solution - 35%, Amino acids solution - 11.1%, Lipid emulsion - 20%, Sodium - 70mmol/2l, Potassium - 60mmol/2l, Magnesium - 8mmol/2l, Calcium - 7mmol/2l, Phosphate - 30mmol/2l, Acetate - 89mmol/2l, Chloride - 90mmol/2l, Azote - 14g/2l		Injectable emulsion	4,929,214 L.L
C09DA08	OLMETEC PLUS	B	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	981,005 L.L
R01AB06	OTRIVIN DUAL RELIEF	B	Xylometazoline HCl - 0.5mg/ml, Ipratropium bromide - 0.6mg/ml		Solution	563,070 L.L
C09DA08	OLMETEC PLUS	B	Olmesartan medoxomil - 20mg, Hydrochlorothiazide - 25mg		Tablet, film coated	946,065 L.L
H01CC01	ORGALUTRAN	B	Ganirelix - 0.25mg/0.5ml	0.25mg/0.5ml	Injectable solution	2,383,977 L.L
R01AD08	OTRIALLERGY	B	Fluticasone propionate - 50mcg/actuation	50mcg/actuation	Spray, suspension	675,953 L.L
C09DA08	OLMETEC PLUS	B	Olmesartan medoxomil - 20mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	946,065 L.L
J01XA05	ORBACTIV	B	Oritavancin (diphosphate) - 400mg	400mg	Injectable powder for concentrate for solution + solvent	157,078,205 L.L
L01EX09	OFEV	B	Nintedanib - 100mg	100mg	Capsule, soft	104,970,427 L.L
L01EX09	OFEV	B	Nintedanib - 150mg	150mg	Capsule, soft	209,943,960 L.L
L04AA32	OTEZLA	B	Apremilast - 4x10mg- 4x20mg- 19x30mg		Tablet, film coated	34,751,325 L.L
L04AA32	OTEZLA	B	Apremilast - 30mg	30mg	Tablet, film coated	49,829,454 L.L
L04AA37	OLUMIANT	B	Baricitinib - 2mg	2mg	Tablet, film coated	68,053,864 L.L
L04AA37	OLUMIANT	B	Baricitinib - 4mg	4mg	Tablet, film coated	68,053,864 L.L
L01XX24	ONCASPAR	B	Pegaspargase - 750U/ml	750U/ml	Injectable powder for solution	L.L
R03AC18	ONBREZ BREEZHALER	B	Indacaterol maleate - 150mcg	150mcg	Capsule, inhalation	2,284,532 L.L

...